Cargando…

Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity associated with clinically significant impairment in functioning. ADHD has an early onset, but frequently persists, with a prevalence estimate of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koblan, Kenneth S, Hopkins, Seth C, Sarma, Kaushik, Jin, Fengbin, Goldman, Robert, Kollins, Scott H, Loebel, Antony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864650/ https://www.ncbi.nlm.nih.gov/pubmed/25948101 http://dx.doi.org/10.1038/npp.2015.124

Ejemplares similares

Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
por: Hopkins, Seth C., et al.
Publicado: (2015)

Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2019)

The rate of dasotraline brain entry is slow following intravenous administration
por: Lew, Robert, et al.
Publicado: (2020)

Absorption, distribution, metabolism, and excretion of [(14)C]‐dasotraline in humans
por: Chen, Yu‐Luan, et al.
Publicado: (2016)

Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial
por: Grilo, Carlos M., et al.
Publicado: (2021)

T109. CLUSTERING OF SCHIZOPHRENIA PATIENT SUBTYPES BY SPECIFIC SYMPTOM DIMENSIONS USING AN UNCORRELATED PANSS SCORE MATRIX (UPSM)
por: Hopkins, Seth, et al.
Publicado: (2018)

Transformed PANSS Factors Intended to Reduce Pseudospecificity Among Symptom Domains and Enhance Understanding of Symptom Change in Antipsychotic-Treated Patients With Schizophrenia
por: Hopkins, Seth C, et al.
Publicado: (2018)

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study
por: Correll, Christoph U., et al.
Publicado: (2021)

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study
por: Childress, Ann C., et al.
Publicado: (2015)

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
por: Wigal, Sharon B, et al.
Publicado: (2009)

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
por: Wigal, Sharon B, et al.
Publicado: (2010)

Pre-Pregnancy Weight and Symptoms of Attention Deficit Hyperactivity Disorder and Executive Functioning Behaviors in Preschool Children
por: Fuemmeler, Bernard F., et al.
Publicado: (2019)

Management of attention-deficit hyperactivity disorder
por: Verma, Rohit, et al.
Publicado: (2011)

The history of attention deficit hyperactivity disorder
por: Lange, Klaus W., et al.
Publicado: (2010)

Stigma in attention deficit hyperactivity disorder
por: Mueller, Anna K., et al.
Publicado: (2012)

Attention Deficit Hyperactivity Disorder and Athletes
por: White, Russell D., et al.
Publicado: (2014)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Neuroimaging in attention-deficit/hyperactivity disorder
por: Pereira-Sanchez, Victor, et al.
Publicado: (2021)

Attention-deficit/hyperactive disorder updates
por: Kessi, Miriam, et al.
Publicado: (2022)

Association between Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms and obesity and hypertension in early adulthood: A population-based study
por: Fuemmeler, Bernard F., et al.
Publicado: (2010)

A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR(®)) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
por: Adjei, Akwete L., et al.
Publicado: (2020)

Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5‐HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders
por: Hopkins, Seth C., et al.
Publicado: (2021)

Attention-deficit-hyperactivity disorder and reward deficiency syndrome
por: Blum, Kenneth, et al.
Publicado: (2008)

Attention deficit hyperactivity disorder (ADHD) & COVID-19: Attention deficit hyperactivity disorder: Consequences of the 1st wave
por: Insa, I., et al.
Publicado: (2021)

Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD
por: Davis, Naomi O., et al.
Publicado: (2018)

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
por: Huss, Michael, et al.
Publicado: (2013)

Training of attention functions in children with attention deficit hyperactivity disorder
por: Tucha, Oliver, et al.
Publicado: (2011)

Connectivity supporting attention in children with attention deficit hyperactivity disorder
por: Barber, Anita D., et al.
Publicado: (2014)

Attention Patterns in Children with Attention Deficit Disorder with or without Hyperactivity
por: Zalsman, Gil, et al.
Publicado: (2003)

Neurophysiological Correlates of Attentional Fluctuation in Attention-Deficit/Hyperactivity Disorder
por: Cheung, Celeste H. M., et al.
Publicado: (2017)

Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study
por: Mansell, Holly, et al.
Publicado: (2021)

Methylphenidate is more effective to improve inhibitory control and working memory compared to tDCS in children and adolescents with attention deficit/hyperactivity disorder: a proof-of-concept study
por: D’Aiello, Barbara, et al.
Publicado: (2023)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Animal models of attention-deficit hyperactivity disorder
por: Russell, Vivienne A, et al.
Publicado: (2005)

Attention Deficit Hyperactivity Disorder in Epileptic Children
por: Kim, Gun-Ha, et al.
Publicado: (2012)

Attention-deficit/hyperactivity disorder in postsecondary students
por: Nugent, Kevin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hsi32fdtqcrqiikljdasrlf3nk